L3VLUP
ProSign in

BFLY · LLY in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

BFLYLLY
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • BFLY
  • LLY
0204060202120222023202420252026
Holders and value by quarter
QuarterBFLYLLY
Q3 2020none listed holders, n.a.33 holders, $14.1bn
Q4 20201 holders, $19m29 holders, $17.3bn
Q1 20213 holders, $191m24 holders, $23.0bn
Q2 20213 holders, $215m24 holders, $27.8bn
Q3 20213 holders, $148m31 holders, $29.9bn
Q4 20213 holders, $98m31 holders, $34.7bn
Q1 20223 holders, $71m24 holders, $35.3bn
Q2 20223 holders, $45m33 holders, $42.7bn
Q3 20223 holders, $86m31 holders, $43.4bn
Q4 20223 holders, $43m31 holders, $46.6bn
Q1 20232 holders, $33m33 holders, $44.3bn
Q2 20232 holders, $48m37 holders, $59.6bn
Q3 20232 holders, $24m44 holders, $67.6bn
Q4 20232 holders, $23m45 holders, $73.6bn
Q1 20242 holders, $21m41 holders, $95.3bn
Q2 20242 holders, $16m43 holders, $110bn
Q3 20242 holders, $33m45 holders, $107bn
Q4 20243 holders, $54m46 holders, $93.9bn
Q1 20253 holders, $58m42 holders, $98.4bn
Q2 20254 holders, $50m43 holders, $93.2bn
Q3 20252 holders, $31m39 holders, $86.7bn
Q4 20253 holders, $80m41 holders, $123bn
Q1 20263 holders, $81m39 holders, $106bn
Q2 20265 holders, $183m44 holders, $132bn
BFLY

Butterfly Network Inc

Holders
2
Reported value
$33m
Buyers
1
Sellers
1

Breadth 0 among 94 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUPSurgical, medical and electromedical devices
LLY

Eli Lilly & Co

Holders
45
Reported value
$107bn
Buyers
24
Sellers
22

Breadth +2 among 94 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q3 2024

Among the 47 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Both (0)

No tracked manager lists every one of them.

Only BFLY (2)

ARK Investment Management LLC, Glenview Capital Management LLC

Only LLY (45)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, Caxton Associates LLP, Citadel Advisors LLC, Coatue Management LLC, D. E. Shaw & Co., Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), GAMCO Investors Inc, Holocene Advisors LP, Hudson Bay Capital Management LP, Invesco Ltd, Jane Street Group LLC, Janus Henderson Group Ltd, Man Group PLC, Marshall Wace LLP, and 20 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →